Fredun Pharmaceuticals Ltd

539730·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap2470.46 Cr
PE Ratio100.39
Volume—
Day High - Low—
52W High-Low1590.00 - 1400.00

Fredun Pharmaceuticals Ltd (539730): company summary

Fredun Pharmaceuticals Ltd (539730) is a micro-cap Healthcare company valued at ₹2,470 crore operating in Pharmaceuticals on the NSE and BSE.

Fredun Pharmaceuticals Ltd (539730) is a micro-cap Healthcare company valued at ₹2,470 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing strongly at 32.5% a year over three years; profit grew 43.6% a year, ahead of revenue — margins are expanding. Return on equity is 15.8%.
Valuation multiples
The stock trades at 100.4 times earnings, a premium to the Healthcare median of 32.5, 9.14 times book value. It yields 0.1%.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
15.80%
Strong
P/E
100.39x
Expensive
Debt / Equity
0.80
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W₹1400
₹1590
DocStoX take

Supported by growth (10.0), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Medium confidence
4.5
/10
Weak
Quality
Modest
ROE 15.8%
Valuation
Expensive
P/E 100.4×
Growth
Strong
Revenue +36.7% 5Y CAGR
Risk
Elevated
D/E 0.80
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹2,470 Cr
52W High / Low
₹1590 / ₹1400
Dividend Yield
0.05%
Promoter Holding
44.57%
EPS (TTM)
₹14.65
Book Value
₹162.78

Key highlights

  • Profit compounding 75% a year
  • Revenue compounding 37% a year
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 100× earnings
3 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Fredun Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Fredun Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESMANIPAL HEALTH ENTERPRI LLUPIN LIMITED

Compare Fredun Pharmaceuticals Ltd with peers

Fredun Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LFredun Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDFredun Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LFredun Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. LFredun Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDFredun Pharmaceuticals Ltd vs CIPLA LTD

Related tools & concepts

Value Fredun Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing